Indometacin Fiterman

Indometacin, the active ingredient in Indometacin Fiterman, is a nonsteroidal anti-inflammatory drug presented as a topical formulation for cutaneous use. It reduces pain and inflammation associated with rheumatic and musculoskeletal conditions in adult patients.

GNH USA supplies Indometacin Fiterman as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides regulatory documentation for each batch. Customers benefit from reliable logistics, temperature‑controlled shipping where required, and dedicated technical support throughout the procurement process.

Indometacin is employed in several inflammatory and musculoskeletal disorders where cyclo‑oxygenase inhibition reduces symptoms.

Rheumatoid arthritis: alleviates joint pain, swelling and stiffness in adult patients. Osteoarthritis: decreases pain and improves joint function in affected joints. Ankylosing spondylitis: reduces spinal inflammation and associated discomfort. Acute gouty arthritis: relieves severe joint pain and inflammation during gout attacks. Post‑operative pain: provides analgesia for surgical wound inflammation.

Topical indometacin may cause local and systemic adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Skin irritation or burning at the application site - Erythema or redness of the skin - Pruritus (itching) - Dryness or peeling of the skin - Headache - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Severe allergic reactions such as anaphylaxis - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Ulceration or bleeding of the gastrointestinal tract - Renal impairment or acute kidney injury - Hepatic dysfunction including elevated liver enzymes - Blood dyscrasias such as thrombocytopenia

When using indometacin, clinicians should consider several safety measures to minimize risk.

Assess renal function: avoid use in patients with severe renal impairment. Monitor gastrointestinal risk: consider gastro‑protective agents in those with ulcer history. Avoid in known hypersensitivity: discontinue if rash or swelling occurs. Caution in cardiovascular disease: NSAIDs may increase thrombotic risk. Limit use during pregnancy: safety not established, especially in third trimester. Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Indometacin can interact with other medicines, requiring careful assessment before co‑administration.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity. - Lithium: elevated serum lithium concentrations.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible decline in renal function. - Corticosteroids: heightened risk of gastrointestinal ulceration.